HOXA13: A Potential Drug Target and Biomarker (G3209)

Target Name: HOXA13

NCBI ID: G3209

HOXA13

HOXA13: A Potential Drug Target and Biomarker

Homeobox proteins (HoxA13) are a family of genes that play a crucial role in the development and maintenance of various tissues and organs in the body. HoxA13 is a member of the HoxA13 gene family, which has been implicated in a wide range of physiological processes, including embryonic development, tissue repair, and stress resistance.

The HoxA13 gene has four splice variants, which result in the production of four different isoforms of the protein: HoxA13-1, HoxA13-2, HoxA13-3, and HoxA13-4. HoxA13-1 is the most abundant isoform, and it is involved in the development and maintenance of the neural tube, which forms the brain and spinal cord. HoxA13-2 is involved in the development of the limbs and in the regulation of cell growth, while HoxA13-3 is involved in the development of the heart and in the regulation of cell differentiation. HoxA13-4 is the least abundant isoform and is involved in the development of the liver and in the regulation of cell growth.

HOXA13 is a protein that is expressed in a wide range of tissues and organs, including the brain, spinal cord, limbs, heart, and liver. It is involved in the development and maintenance of these tissues and is a potential drug target or biomarker.

Drug Target Potential

HOXA13 has been identified as a potential drug target due to its involvement in the development and maintenance of various tissues and organs. HoxA13 has been shown to play a role in the development and maintenance of the neural tube, which forms the brain and spinal cord.

Studies have shown that HoxA13 is involved in the regulation of neural tube development and that it is a critical factor in the formation of the neural tube. HoxA13 has also been shown to play a role in the regulation of cell growth and differentiation, which is important for the development and maintenance of various tissues and organs.

In addition to its role in neural tube development and cell growth, HoxA13 has also been shown to be involved in the regulation of stress resistance. Studies have shown that HoxA13 is involved in the regulation of cellular stress responses and that it is a critical factor in the regulation of stress resistance.

Biomarker Potential

HOXA13 has also been identified as a potential biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. HoxA13 has been shown to be involved in the development and maintenance of various tissues and organs, which makes it a potential biomarker for a wide range of diseases.

Studies have shown that HoxA13 is involved in the development and maintenance of cancer cells. HoxA13 has been shown to play a role in the regulation of cell growth and differentiation, which is important for the development and maintenance of cancer cells.

HOXA13 has also been shown to be involved in the development and maintenance of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. HoxA13 has been shown to play a role in the regulation of cellular stress responses and in the development of neurodegenerate diseases.

HOXA13 has also been shown to be involved in the development and maintenance of autoimmune diseases, such as rheumatoid arthritis and type 1 diabetes. HoxA13 has been shown to play a role in the regulation of immune responses and in the development of autoimmune diseases.

Conclusion

HOXA13 is a protein that is involved in the development and maintenance of various tissues and organs. It has been identified as a potential drug target due to its involvement in the development and maintenance of the neural tube and various tissues and organs. HoxA13 is also a potential biomarker for a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Further research is needed to fully understand the role of HoxA13 in these processes and to develop new treatments for these diseases.

Protein Name: Homeobox A13

Functions: Sequence-specific, AT-rich binding transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis

The "HOXA13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HOXA13 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets